Advanced Solid Tumors: PM534 Treatment

We are testing a new drug called PM534 for patients with advanced solid tumors. The goal is to learn about its safety and how it may help in treating this condition.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Hospital General Universitario Gregorio Maranon
Oncology
Ciudad Lineal, Spain
Institut Catala D'oncologia
Oncology
L'Hospitalet de Llobregat, Spain
Hospital San Pedro
Oncology
Logroño, Spain
Sponsor: Pharma Mar S.A.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.